Article citationsMore>>

D. L. Noah, K. Y. Twu and R. M. Krug, “Cellular Antiviral Responses against Influenza A Virus Are Countered at the Post Transcriptional Level by the Viral NS1A Protein via Its Binding to a Cellular Protein Required for the 3’End Processing of Cellular Pre-mRNAS,” Virology, Vol. 307, No. 2, 2003, pp. 386-395. doi:10.1016/S0042-6822(02)00127-7

has been cited by the following article:

• TITLE: Screening of Potent Inhibitor of H1N1 Influenza NS1 CPSF30 Binding Pocket by Molecular Docking

  AUTHORS: Li Zhang, Jian Zhao, Guowei Ding, Xuejiao Li, Hongsheng Liu

  KEYWORDS: CPSF30 Binding Pocket; Molecular Docking; Influenza A H1N1

  JOURNAL NAME: Advances in Infectious Diseases, Vol.2 No.4, December 5, 2012

  ABSTRACT: The swine flu, H1N1 virus was outbroken in Mexico and the United States in April 2009 and then rapidly spread worldwide. The World Health Organization declared that the outbreak of influenza is caused by a new subtype of influenza H1N1 influenza virus. And researchers have isolated some oseltamivir resistance strains in 2009 swine flu which makes the imminency of research and development of new anti influenza drug. The CPSF30 binding pocket of effector domain in NS1 protein is very important in the replication of influanza A virus and is a new attractive anti flu drug target. But up to now there is no antiviral drug target this pocket. Here we employ molecular docking to screening of about 200,000 compounds. We find four novel compounds with high binding energy. Binding comformation analysis revealed that these small molecules can interact with the binding pocket by some strong hydrophobic interaction. This study find some novel small molecules can be used as lead compounds in the development of new antiinfluenza drug based on CPSF30 pocket.